SAN FRANCISCO — Despite all the hopeful chatter about the life sciences industry making a rebound after a multiyear ...

Venture investors are adopting a more aggressive mindset heading into 2026, while Merck, Moderna and Summit are all ...

The firm is expecting a slew of key readouts for mRNA vaccines for treating cancer and rare diseases and is exploring vaccines for autoimmune conditions.

Moderna stock soared in the early stages of the pandemic, then struggled -- but in recent times, it’s been on the rise. This other biotech has proven itself as a long-term winner. This stock is a ...

Initiate Moderna with a Hold rating at a $25 target price (lower than the current price), citing balanced risk-reward despite the advanced mRNA platform and robust pipeline. MRNA's near-term execution ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Stéphane Bancel, Moderna’s ...

Moderna has rallied ~23%, but I maintain a 'Sell' and 'market underperform' rating due to deteriorating fundamentals. MRNA’s recent rally is driven by improved liquidity, cost discipline, and a $1.5 ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min After donating $176 million in ...

The CEO of SpaceX rival United Launch Alliance, Tory Bruno, has resigned after 12 years on the job “to pursue another opportunity,” according to the company. “We are grateful for Tory’s service to ULA ...

Dec 18 (Reuters) - Moderna (MRNA.O), opens new tab will get up to $54.3 million in funding from a global coalition to support late-stage development of its experimental bird flu vaccine, the U.S.

Moderna Inc. will get as much as $54.3 million for a late-stage trial of its bird flu vaccine in a sign of how outside groups could help fill the void after the Trump administration slashed federal ...

(The Hill) — Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research into a potential bird flu mRNA vaccine, helping to recover ...